Posted by Michael Wonder on 04 Sep 2019
Capital Rx to inject transparency in prescription drug prices
4 September 2019 - In recent years, the pharmacy benefits management industry's pricing practices have been under intense scrutiny by legislators and the Trump Administration.
Today the pharmacy benefit manger (PBM) Capital Rx is launching its Clearinghouse Model, a novel pricing framework intended to disrupt the PBM industry's pricing practices.
Founded two years ago, Capital Rx is a PBM that manages prescription drug benefits on behalf of employers, unions, and government entities. Besides healthcare analytics, claim adjudication, and clinical services, Capital Rx carries out retail network pricing of prescription drug products. The company's declared mission is to "change the way prescription benefits are priced and administered in the U.S."
